Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-07-08

Clinical Trial Update: Apixaban Versus Warfarin in Patients With Left Ventricular Thrombus [Phase 3]

View source ↗

Summary

Phase 3 trial comparing apixaban to warfarin in patients with left ventricular thrombosis has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Apixaban (apixaban)
  • Warfarin (warfarin)

Snippet

Sponsor: Universiti Sains Malaysia | Conditions: Left Ventricular Thrombosis | Phase 3 | Status: COMPLETED | Results posted: 2021-07-08